G. Perrocheau

Single-Agent Gemcitabine Is Active in Previously Treated Metastatic Breast Cancer

M. Spielmann, Antonio Llombart‐Cussac, Salima Kalla et al. · Oncology · 2001 · 140 citations

Medicine, Oncology, Pharmacology +17

Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas.

R. Féty, F. Rolland, Muriel Barberi‐Heyob et al. · PubMed · 1998 · 114 citations

Pharmacy, Oncology, Pharmacology +17

Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients

Emmanuelle Jacquet, Audrey Lardy-Cléaud, Barbara Pistilli et al. · European Journal of Cancer · 2018 · 67 citations

Medicine, Endocrinology, Oncology +14

The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)

David Pérol, Mathieu Robain, Patrick Arveux et al. · BMJ Open · 2019 · 67 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Docetaxel combined with vinorelbine: phase I results and new study designs.

P. Fumoleau, R. Féty, Delecroix et al. · PubMed · 1997 · 26 citations

Medicine, Oncology, Pharmacology +14